Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy
Open Access
- 3 December 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 2791
Abstract
Chagas disease is caused by infection with the protozoan Trypanosoma cruzi and affects over 8 million people worldwide. In spite of a powerful innate and adaptive immune response in acute infection, the parasite evades eradication, leading to a chronic persistent infection with low parasitism. Chronically infected subjects display differential patterns of disease progression. While 30% develop chronic Chagas disease cardiomyopathy (CCC)—a severe inflammatory dilated cardiomyopathy—decades after infection, 60% of the patients remain disease-free, in the asymptomatic/indeterminate (ASY) form, and 10% develop gastrointestinal disease. Infection of genetically deficient mice provided a map of genes relevant for resistance to T. cruzi infection, leading to the identification of multiple genes linked to survival to infection. These include pathogen resistance genes (PRG) needed for intracellular parasite destruction, and genes involved in disease tolerance (protection against tissue damage and acute phase death—DTG). All identified DTGs were found to directly or indirectly inhibit IFN-γ production or Th1 differentiation. We hypothesize that the absolute need for DTG to control potentially lethal IFN-γ PRG activity leads to T. cruzi persistence and establishment of chronic infection. IFN-γ production is higher in CCC than ASY patients, and is the most highly expressed cytokine in CCC hearts. Key DTGs that downmodulate IFN-γ, like IL-10, and Ebi3/IL27p28, are higher in ASY patients. Polymorphisms in PRG and DTG are associated with differential disease progression. We thus hypothesize that ASY patients are disease tolerant, while an imbalance of DTG and IFN-γ PRG activity leads to the inflammatory heart damage of CCC.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/50302-3, 2014/50890-5, 2016/15209-0)
This publication has 151 references indexed in Scilit:
- STAT1/3 and ERK1/2 Synergistically Regulate Cardiac Fibrosis Induced by High GlucoseCellular Physiology and Biochemistry, 2013
- Host cell invasion byTrypanosoma cruzi: a unique strategy that promotes persistenceFEMS Microbiology Reviews, 2012
- The Immune Response toTrypanosoma cruzi: Role of Toll-Like Receptors and Perspectives for Vaccine DevelopmentJournal of Parasitology Research, 2012
- In SituExpression of Regulatory Cytokines by Heart Inflammatory Cells in Chagas' Disease Patients with Heart FailureJournal of Immunology Research, 2012
- Up-regulation and Sustained Activation of Stat1 Are Essential for Interferon-γ (IFN-γ)-induced Dual Oxidase 2 (Duox2) and Dual Oxidase A2 (DuoxA2) Expression in Human Pancreatic Cancer Cell LinesJournal of Biological Chemistry, 2011
- Intraphagosomal Peroxynitrite as a Macrophage-derived Cytotoxin against Internalized Trypanosoma cruziJournal of Biological Chemistry, 2011
- Downregulation of Robust Acute Type I Interferon Responses Distinguishes Nonpathogenic Simian Immunodeficiency Virus (SIV) Infection of Natural Hosts from Pathogenic SIV Infection of Rhesus MacaquesJournal of Virology, 2010
- A novel immunoregulatory function for IL‐23: Inhibition of IL‐12‐dependent IFN‐γ productionEuropean Journal of Immunology, 2010
- Structural conservation of interferon gamma among vertebratesCytokine & Growth Factor Reviews, 2009
- A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosisNature Genetics, 2007